Dasatinib Recruiting Phase 4 Trials for Hematological Neoplasms Treatment

IndicationsStatusPurposePhase
RecruitingTreatment4
clinicaltrials.gov IdentifierTitleDrugs
NCT03844360Dose Individualization of Antineoplastic Drugs and Anti-Infective Drug in Children With Hematoplastic Disease